New rabies vaccine candidate demonstrates promising immune response and safety
Published on July 28, 2022
Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG - with promising results identified.